Survey of Potential Drug Rebates Associated With Drugs Administered to Enrollees in Separate Children's Health Insurance Programs
Under current Federal requirements, States are required to obtain drug rebates from manufacturers for Medicaid-covered outpatient prescription drugs that are provided through Medicaid expansion-under either: (1) Medicaid expansion only or (2) the Medicaid expansion portion if the State chooses a combination of Medicaid expansion and a separate Children's Health Insurance Program (CHIP). However, for prescription drugs that are funded through a separate CHIP, the Federal Medicaid Drug Rebate Program (MDRP) requirements currently do not apply. We will determine the total drug rebates that States could potentially have collected under separate CHIPs if those rebates had been part of the MDRP requirements and we will identify State policy differences.
|Announced or Revised||Agency||Title||Component||Report Number(s)||Expected Issue Date (FY)|
|December 2021||Centers for Medicare and Medicaid Services||Survey of Potential Drug Rebates Associated With Drugs Administered to Enrollees in Separate Children's Health Insurance Programs||Office of Audit Services||W-00-22-35880||2022|